Persona grata · by sector, not by name
Built for whoeveractually files.
Eight sectors carry the patents the world depends on. Pick the one that looks like your week — landscape, FTO, claim drafting and the 69-failure cartography are already wired for it.
Eight sectors · one platform
Whoever actually files, we already know your week.
Pick the sector that maps to your week. Each card routes to the pricing tier we ship for that workflow — no detail page in between.
Pharma R&D
Big Pharma R&D
Top-20 pharma · IP departments · 1000+ FTE
Two hundred molecule briefs land per quarter. The cabinet audits five. The other one hundred ninety-five ship into discovery without an FTO, and G 2/21 plausibility is one opposition away from gutting the pipeline.
Unlocks · Full landscape, FTO obsessionnel and plausibility check on every brief in 8 minutes — the cabinet only sees the ten with positive scores.
200 / 200 briefs FTO'd / quarter
Up from 5 audited. Same headcount.
Buyer · IP DirectorBiotech Startup
Biotech startup
Series A–C · AI-driven discovery
Cabinet quote is €18–45k / yr for FTO. Reaxys is €50k. The Series-B story needs a US portfolio in 18 months and the runway does not stretch to both.
Unlocks · The Founder plan unlocks the full table — landscape, PROV drafts, FTO scans, US/EP coverage — at startup-budget elasticity.
€24k / yr unlocks the table stakes
Pay-as-you-grow. Scales to €192k at Series B.
Buyer · CSO / FounderPatent Counsel
Patent counsel firm
CPI · EPO / USPTO mandataires · 5–50 attorneys
Forty hours per provisional, thirty PROV per year, juniors that miss G 1/24 claim construction and Amgen §112 enablement. Margin is dying under rewrite cost.
Unlocks · The Claim Interpretation Lattice pre-drafts the cascade-4-couches and applies the legal cartography. You review, sign, file.
40 h → 4 h per provisional
Same partner, 10× throughput, no junior burnout.
Buyer · Equity PartnerAcademic & TTOs
Academic & TTOs
Universities · INSERM · CNRS · Fraunhofer · MIT
Hundreds of disclosure forms a year, a fixed PCT budget, and a triage queue that lets defensible inventions die in the inbox. Most labs never see the first office action.
Unlocks · Run every disclosure through landscape and patentability scoring at marginal cost — license decisions become evidence-based.
10× more inventions screened
Same TTO budget, evidence-based triage.
Buyer · TTO DirectorGenerics · ANDA
Generics & ANDA strategy
Hatch-Waxman counsel · Paragraph IV teams
Designing around an Orange-Book listing means enumerating every bioisostere a court will read into the claim. Manual analysis stops at five interpretations; the case turns on the sixth.
Unlocks · Bioisostere mapping × the 6-axis CIL builds a defensible non-infringement position before the Paragraph IV letter goes out.
Bioisostere × 6-axis lattice in 8 min
Replaces a 3-week mandataire pre-suit memo.
Buyer · Litigation PartnerInvestment DD
Investment due diligence
VCs · Series-B/C/D · M&A IP advisors
Thirty portcos, one IP analyst, and Helsinn / on-sale bar risk hiding in every data room. The current playbook is a half-day conversation per check.
Unlocks · Run a structured IP risk audit — landscape, FTO, on-sale exposure, inventorship — in one afternoon, on every portco.
IP risk audit on 30 portcos / quarter
From a quarterly headache to a standing report.
Buyer · Investment PartnerCorporate Legal
Corporate legal department
Fortune-500 · in-house IP counsel
Outside counsel retainers run seven figures, with FTC v. Actavis scrutiny on every secondary filing. The board wants the spend defended line by line.
Unlocks · Move clearance, plausibility and lifecycle review in-house on a white-label deployment with a dedicated patent strategist.
Cabinet retainers cut 60–80%
Outside spend reallocates to litigation and licensing.
Buyer · Chief IP CounselEnterpriseSovereign R&D
Sovereign R&D · govt + defense
DoD · DGA · JEDI · BARDA · EU Horizon
Classified programmes need landscape and freedom-to-operate without a single byte leaving the perimeter. Commercial SaaS is a non-starter; the cabinet workflow is too slow for a six-month grant cycle.
Unlocks · Air-gapped, on-prem deployment of the full CIL stack with dedicated legal cartography updates and cleared support.
On-prem + air-gap deployment
Custom legal cartography. Cleared support channel.
Buyer · Programme OfficeEnterprise
Side by side
Today, without IPZilla. Tomorrow, with the lattice.
Three representative sectors. Same job-to-be-done. The numbers are the only thing that changes.
| Sector | Today (without IPZilla) | With IPZilla |
|---|---|---|
| Pharma R&DIP Director | 5 of 200 briefs audited | 200 of 200, 8 min each |
| BiotechFounder / CSO | €18–45k / yr cabinet FTO retainer | €24k / yr · Founder plan |
| Patent counselCPI · EPO / USPTO | 40 h drafting per provisional | 4 h with CIL pre-draft |
Pharma R&D
IP Director
- Today
- 5 of 200 briefs audited
- With IPZilla
- 200 of 200, 8 min each
Biotech
Founder / CSO
- Today
- €18–45k / yr cabinet FTO retainer
- With IPZilla
- €24k / yr · Founder plan
Patent counsel
CPI · EPO / USPTO
- Today
- 40 h drafting per provisional
- With IPZilla
- 4 h with CIL pre-draft
Pick your sector
Eight workflows. One platform underneath.
Choose the tier sized to your sector — or talk to us if your deployment touches sovereignty, white-label, or air-gapped infra.
Founder · €24k / yr · Scale · €192k / yr · Enterprise · on request